Metabolic flux distribution for the
optimized production of L-glutamate
Serpil Takac ¸,* Gu ¨zide C ¸ alık,* Ferda Mavituna,
²
and George Dervakos
²
*Industrial Biotechnology Department, Ankara University Biotechnology Research Center, Ankara,
Turkey;
²
Department of Chemical Engineering, UMIST, Manchester, U.K.
A comprehensive metabolic network was proposed for glutamic acid bacteria and used in a stoichiometrically
based flux balance model for L-glutamate production. Theoretical metabolic pathways leading to optimized
glutamate overproduction were determined for several specific cell growth rates; variation in the fluxes was
obtained. The off-line extracellular analyses throughout the batch fermentation with Brevibacterium flavum
showed the accumulation of arginine, aspartate, lysine, alanine, proline, lactate, -ketoglutarate, succinate,
pyruvate, and gluconate in the medium in addition to glutamate. Metabolic flux distributions in the cells
throughout the fermentation were determined using the model in combination with the extracellular analyses of
the metabolites. The flux distribution maps showed that the cells utilized the TCA cycle in part whereas the
glyoxylate bypass was active throughout the fermentation. The results also indicated that the phosphate pentose
shunt played an important role in the glutamate fermentation. These diversions in the pathways and certain
metabolic reactions depending on the fermentation periods and conditions are also presented in this paper.
© 1998 Elsevier Science Inc.
Keywords: Metabolic pathways; flux distribution; optimization; l-glutamate; glutamic acid bacteria
Introduction
l-Glutamate (Glu) which is in widespread use throughout
the world as a seasoning as well as a starting material for the
synthesis of various chemicals is produced industrially by
fermentation using Brevibacterium and Corynebacterium
strains.
1
The wild strains of glutamic acid bacteria seem to
be able to produce only small amounts of the amino acids
extracellularly; therefore, several methods have been em-
ployed to alter the cellular metabolism and regulatory
controls of the bacteria including cell mutation, cell fusion,
and genetic manipulation techniques.
2
However, since the
analysis of metabolic flux distribution in an organism can
provide information about the bottlenecks in the overpro-
duction of the desired metabolite, studies should now focus
on metabolic pathway engineering. In this field, stoichio-
metrically based flux balance models have attracted a great
deal of interest. Escherichia coli is well studied in compar-
ison with other bacteria and a lot of information regarding
its metabolic system leading to amino acid production is
readily available in the literature. This availability of infor-
mation has become a good reason to apply such models
primarily to E. coli.
The central metabolic pathways of E. coli during the
growth on several carbon sources were investigated by
Holms
3
using the stoichiometric flux analysis that depends
on the knowledge of biochemical stoichiometry, biosynthe-
sis requirements, and on the measurements of the flows in
and out of the cells. The metabolic capabilities of E. coli to
produce some precursors and key cofactors were reported in
detail by Varma and Palsson.
4
The fueling reactions and
electron transfer system occurring in E. coli were presented
by these authors. Linear optimization was used to determine
the bounds of the flux distribution that the bacteria could
achieve. In their following article, Varma and Palsson
5
investigated the effect of metabolic stoichiometry on the
cellular function and behavior of E. coli. The optimal
growth patterns on glucose (Glc) and acetate (Ac) as well as
the effects of pathways utilized, metabolic demands, P/O
ratio, and maintenance requirement on the solution of the
Address reprint requests to Dr. Serpil Takac ¸, Ankara University, Depart-
ment of Chemical Engineering, Tandog ˘an, Ankara, 06100 Turkey
Received 30 July 1997; revised 24 March 1998; accepted 31 March 1998
Enzyme and Microbial Technology 23:286 –300, 1998
© 1998 Elsevier Science Inc. All rights reserved. 0141-0229/98/$19.00
655 Avenue of the Americas, New York, NY 10010 PII S0141-0229(98)00047-7